Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Silun, Xie"'
Publikováno v:
OncoTargets and Therapy. 15:255-266
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64eb528dab867f3e779329318dbb0987
https://doi.org/10.2147/ott.s344707
https://doi.org/10.2147/ott.s344707
Publikováno v:
OncoTargets and Therapy. 12:5077-5086
Background: Natural killer (NK) cells can be used as an adoptive immunotherapy to treat cancer patients. Purpose: In this study, we evaluated the efficacy of highly activated NK (HANK) cell immunotherapy in patients with advanced lung cancer. Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bd61a495deb3a4ba652fdfabf3e04c3
https://doi.org/10.2147/ott.s201924
https://doi.org/10.2147/ott.s201924
Autor:
Xiaohua Wang, Zhengyi Wu, Mingjie Zhang, Silun Xie, Lizhi Niu, Jibing Chen, Kecheng Xu, Yingqing Liang, Liang Zhou
Publikováno v:
OncoTargets and therapy
For advanced hepatocellular carcinoma (HCC) patients, liver transplantation (LT) is an optimal treatment with limitation of high risk of tumor recurrence related to the immunosuppressive chemotherapy as usually recommended. In this study, a 29-year-o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c44de8f3f9d23fe335fc28376fe6aff
https://doi.org/10.2147/ott.s166962
https://doi.org/10.2147/ott.s166962
Publikováno v:
Molecular & Clinical Oncology. 2017, Vol. 6 Issue 6, p903-906. 4p.
Publikováno v:
OncoTargets and therapy
Background: Natural killer (NK) cells can be used as an adoptive immunotherapy to treat cancer patients. Purpose: In this study, we evaluated the efficacy of highly activated NK (HANK) cell immunotherapy in patients with advanced lung cancer. Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc8c27be3230446f19e8c587d0a638f3
https://pubmed.ncbi.nlm.nih.gov/31308687
https://pubmed.ncbi.nlm.nih.gov/31308687
Autor:
Jibing Chen, Silun Xie, Mingjie Zhang, Jianying Zeng, Zhenyi Wu, Xiaohua Wang, Lizhi Niu, Zilin Qin, Yingqing Liang
Publikováno v:
Cancer biologytherapy. 18(5)
We investigated the effectiveness of adoptive transfer of KIR ligand-mismatched highly activated nature killer (HANK) cells in patients with hepatic carcinoma. Peripheral blood mononuclear cells were obtained and cultured in vitro to induce expansion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183dd42d6d5308561a5738851aa4f186
https://pubmed.ncbi.nlm.nih.gov/28353401
https://pubmed.ncbi.nlm.nih.gov/28353401
Publikováno v:
Molecular and Clinical Oncology
Masses are often detected in the abdomen of patients with sizeable ovarian cancer. There are currently no effective treatments available for late-stage ovarian cancer. Immunotherapy is gaining increasing attention worldwide in the clinical setting du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd75c74e1776a34b16af0c2bd5871c0
http://europepmc.org/articles/PMC5649004
http://europepmc.org/articles/PMC5649004